NCT05228067

Brief Summary

Disturbances in the hypothalamus communication pathways with other regions in the brain and the periphery may represent a potential link between metabolic and cognitive health. The current project evaluates whether enhancing synaptic plasticity of this pathway can improve weight management, insulin sensitivity, and cognitive functions. In recent studies, we were able to show that the human brain is sensitive to insulin with favorable effects on peripheral metabolism and cognition. These brain regions encompass the hypothalamus and its connections to the striatum and prefrontal cortex. We want to investigate whether it is possible to enhance neuroplasticity of insulin-responsive brain regions to suppress the weight gain trajectory and improve dopamine-dependent cognitive functions in people with a high risk to develop type 2 diabetes. For this purpose, neuroimaging tools using high-definition transcranial direct current stimulation (HD-tDCS) and magnetic resonance imaging (MRI) will be implemented to assess synaptic plasticity of a neural network essential for metabolic and cognitive health.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 8, 2021

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

November 12, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

February 8, 2022

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

March 30, 2025

Status Verified

March 1, 2025

Enrollment Period

3.1 years

First QC Date

November 12, 2021

Last Update Submit

March 25, 2025

Conditions

Keywords

tDCSMRIhypothalamusfunctional connectivity

Outcome Measures

Primary Outcomes (4)

  • Change in neuroplasticity

    Fractional anisotropy (FA) of the target network

    20 minutes directly before and after tDCS stimulation

  • Change in functional connectivity

    Resting state functional connectivity of the target network

    20 minutes directly before and after tDCS stimulation

  • Change in eating behavior

    Caloric intake (kcal), Free-choice, ad libitum food intake from a standardized breakfast buffet. The caloric intake from fat, carbohydrates and protein will be documented

    1 hour after tDCS stimulation

  • Change in dopamine-dependent cognitive function

    Changes in dopamine-dependent cognitive function and reward sensitivity measured by a reward-based decision-making task

    20 minutes after tDCS stimulation

Secondary Outcomes (4)

  • Change in subjective ratings

    5 minutes before tDCS stimulation, 5 minutes after tDCS stimulation and 5 minutes after buffet

  • Performance during stop-signal task

    task is performed during 25-minutes tDCS stimulation

  • Tastiness and healthiness rating of food stimuli

    task is performed immediately after buffet

  • Food choice

    task is performed immediately after buffet

Study Arms (3)

Anodal stimulation

ACTIVE COMPARATOR

Anodal tDCS of the hypothalamus network

Device: anodal transcranial direct current stimulation

Cathodal stimulation

ACTIVE COMPARATOR

Cathodal tDCS of the hypothalamus network

Device: cathodal transcranial direct current stimulation

Sham stimulation

SHAM COMPARATOR

Sham tDCS of the hypothalamus network

Device: sham transcranial direct current stimulation

Interventions

anodal tDCS of the hypothalamus resting-state functional connectivity network using 12 Electrodes of the Starstim device by Neuroelectrics. The total injected current will never go beyond 4 milliamp, which will be split among the different stimulation electrodes.

Also known as: anodal tDCS, excitatory tDCS
Anodal stimulation

anodal tDCS of the hypothalamus resting-state functional connectivity network using 12 Electrodes of the Starstim device by Neuroelectrics. The total injected current will never go beyond 4 milliamp, which will be split among the different stimulation electrodes.

Also known as: cathodal tDCS, inhibitory tDCS
Cathodal stimulation

Double blind sham stimulation of the hypothalamus resting-state functional connectivity network (ramp-up ramp-down stimulation will be applied for 30 seconds)

Also known as: sham tDCS
Sham stimulation

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Written consent to participate in the study
  • Written consent to be informed about incidental findings
  • Overweight and obese participants:
  • Body mass index (BMI) between 28 and 39.5 kg/m2
  • Age between 20 to 65 years of age
  • Waist circumference \> 80 cm for women, \> 94 cm for men
  • Sex and age matched normal weight individuals:
  • Body mass index (BMI) between 19.5 and 24.5 kg/m2
  • Age between 20 to 65 years of age

You may not qualify if:

  • Insufficient knowledge of the German language
  • Persons who cannot legally give consent
  • Pregnancy or lactation
  • History of severe mental or somatic disorders including neurological diseases (incl. Epileptic seizures)
  • Taking psychotropic drugs
  • Previous bariatric surgery
  • Acute infection within the last 4 weeks
  • Hemoglobin values less than 12g/dl for women, less than 14 g/dl for men
  • Current participation in a lifestyle intervention study or a pharmaceutical study
  • Contradictions to a MRI measurement (e.g. metal implants)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Clinic Tübingen

Tübingen, 72076, Germany

Location

MeSH Terms

Conditions

Insulin ResistanceObesityDiabetes Mellitus, Type 2

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

HyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsDiabetes MellitusEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Stimulation protocol is applied in a double blind fashion.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: All participants receive sham stimulation, anodal stimulation and cathodal stimulation in a pseudo-randomized order on three separate measurement days.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 12, 2021

First Posted

February 8, 2022

Study Start

November 8, 2021

Primary Completion

December 30, 2024

Study Completion

December 31, 2025

Last Updated

March 30, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations